| Amedisys Home Health Care | |
| 729 Richmond Avenue, Suite B, Staunton, Virginia 24401 | |
| (540) 886-2970 | |
| Name | Amedisys Home Health Care |
|---|---|
| Location | 729 Richmond Avenue, Suite B, Staunton, Virginia |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services |
| Medicare ID | 497646 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 22664, 22801, 22802, 22811, 22812, 22815, 22820, 22821, 22827, 22830, 22831, 22834, 22835, 22840, 22841, 22842, 22843, 22844, 22846, 22849, 22850, 22851, 22853, 22920, 22932, 22939, 22952, 22980, 24085, 24401, 24415, 24416, 24421, 24422, 24426, 24430, 24431, 24432, 24435, 24437, 24439, 24440, 24441, 24448, 24450, 24457, 24459, 24460, 24467, 24471, 24472, 24473, 24474, 24477, 24479, 24482, 24483, 24485, 24486, 24555, 24578, 24579 |
| NPI Number | 1073794863 |
| Organization Name | AMEDISYS HOME HEALTH OF VIRGINIA LLC |
| Doing Business As | AMEDISYS HOME HEALTH CARE |
| Address | 729 Richmond Ave, Suite B, Staunton, VA 24401 |
| Phone Number | 540-564-2970 |
News Archive
PolyMedix Inc. (http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today that it has completed a public offering of units for aggregate gross proceeds of $20.7 million.
On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.
Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.
Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.
› Verified 9 days ago
| Quality Rating: |
News Archive
PolyMedix Inc. (http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today that it has completed a public offering of units for aggregate gross proceeds of $20.7 million.
On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.
Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.
Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.9 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
| How often the home health team checked patients for depression | 88.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 84.1 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 94.1 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 96.4 | 96.4 |
News Archive
PolyMedix Inc. (http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today that it has completed a public offering of units for aggregate gross proceeds of $20.7 million.
On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.
Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.
Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 81.9 | 79.6 |
| How often patients got better at getting in and out of bed | 81.1 | 81.1 |
| How often patients got better at bathing | 87.5 | 82.3 |
| How often patients’ breathing improved | 89 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 94.7 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 77.4 | 75 |
| How often home health patients had to be admitted to the hospital | 13.7 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.6 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.3 | 94 |
News Archive
PolyMedix Inc. (http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today that it has completed a public offering of units for aggregate gross proceeds of $20.7 million.
On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.
Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.
Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.
› Verified 9 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
PolyMedix Inc. (http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today that it has completed a public offering of units for aggregate gross proceeds of $20.7 million.
On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.
Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.
Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.
› Verified 9 days ago
The patient survey data of Amedisys Home Health Care is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 83 | 78 |
News Archive
PolyMedix Inc. (http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, announced today that it has completed a public offering of units for aggregate gross proceeds of $20.7 million.
On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.
Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.
Researchers from Skoltech, U.S. companies VirIntel and Argentys Informatics, and two Russian Academy of Sciences institutes have studied the immune response to COVID-19 in patients with different levels of disease severity.
› Verified 9 days ago
Intrepid Usa Healthcare Services Location: The Shops At 222 - 106 Rowe Road, Suite 103, Staunton, Virginia 24401 Ratings: NA Phone: (540) 863-2140 | |
Amedisys Home Health Care Location: 729 Richmond Avenue, Suite B, Staunton, Virginia 24401 Ratings: Phone: (540) 886-2970 |